Cancela Camila S P, Assumpcao Juliana G, Paula Francisco D F, Murao Mitiko, Viana Marcos B, Oliveira Benigna M
Clin Lab. 2018 Jan 1;64(1):205-209. doi: 10.7754/Clin.Lab.2017.170622.
Cytological analysis of the cerebrospinal fluid (CSF) remains the most widely used method for diagnosing central nervous system (CNS) involvement in acute lymphoblastic leukemia (ALL). This study aimed at evaluating the use of polymerase chain reaction (PCR), in comparison to other methods, for the assessment of the presence of blast cells in the CSF at the time of diagnosis of ALL.
This was a prospective, single-centre, study enrolling all patients up to the age of 18 years who were admitted to a university hospital between November 2011 and November 2014 with a diagnosis of ALL and from whom it was possible to draw a sufficient amount of CSF for analysis by conventional cytology (CT), immunophenotyping (IMP), and PCR.
A total of 46 CSF samples from 44 ALL pediatric patients were included. CT was performed in all samples, IMP in 44, and PCR in 34. Thirteen (28.2%) samples showed positive results: two by CT, four by IMP, four by PCR, and three by both IMP and PCR.
The results of this study showed that PCR should be considered a complementary method for the evaluation of the CSF in ALL patients at diagnosis.
脑脊液(CSF)细胞学分析仍然是诊断急性淋巴细胞白血病(ALL)中枢神经系统(CNS)受累最广泛使用的方法。本研究旨在评估与其他方法相比,聚合酶链反应(PCR)在ALL诊断时评估CSF中原始细胞存在情况的应用。
这是一项前瞻性单中心研究,纳入了2011年11月至2014年11月期间入住大学医院、年龄在18岁以下、诊断为ALL且能够抽取足够量CSF进行常规细胞学(CT)、免疫表型分析(IMP)和PCR检测的所有患者。
共纳入44例ALL儿科患者的46份CSF样本。所有样本均进行了CT检测,44份进行了IMP检测,34份进行了PCR检测。13份(28.2%)样本呈阳性结果:CT检测阳性2份,IMP检测阳性4份,PCR检测阳性4份,IMP和PCR检测均阳性3份。
本研究结果表明,PCR应被视为ALL患者诊断时评估CSF的一种补充方法。